Pirfenidone as Treatment of Chronic Pancreatitis

NCT07755813 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Chronic Pancreatitis

Interventions

DRUG: Pirfenidone 267 mg Oral Tablet
DRUG: Placebo
OTHER: PROMIS-Global Health
OTHER: Comprehensive Pain Assessment Tool
OTHER: Brief Pain Inventory
OTHER: Pancreatitis Quality of Life Instrument

Sponsor

Vikas Dudeja

Collaborators

[object Object]